ReviewCancer cell international2025
Cross-talk between cancer-associated fibroblasts and dormant cancer cells: current status and promising therapeutic potential.
Review in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Myofibroblast-Like CAFs in Metastatic Lymph Nodes Drive Tumor Stemness and Poor Prognosis in Head and Neck Cancer.Cancer science · 2026Article
- IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review).International journal of oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cancer-associated stromal cells, particularly cancer-associated fibroblasts (CAFs), are pivotal components of the tumor microenvironment (TME) that significantly influence cancer progression. Communication between CAFs and cancer cells orchestrates key aspects of tumor dynamics, including the induction of dormancy. In response to adverse environmental stimuli, such as hypoxia, chemotherapy, or radiotherapy, cancer cells enter a dormant state, enabling them to evade environmental stimuli. The duration of this dormancy varies with the type, differentiation degree, and proliferation rate of primary cancer. The process is regulated by CAFs through various mediators, including growth factors, chemokines, inflammatory factors, exosomes, etc. Notably, environmental stimuli can induce the formation of polyploid giant cancer cells (PGCCs), a dormant cell type characterized by high drug resistance, tumorigenicity, and stemness. This review summarizes the relationship between CAFs and cancer cell dormancy, and explores the potential mechanisms through which CAFs regulate this process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.